×
Roche Holding AG Total Long Term Liabilities 2010-2023 | RHHBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Roche Holding AG total long term liabilities from 2010 to 2023. Total long term liabilities can be defined as the sum of all non-current liabilities.
View More
Roche Holding AG Total Long Term Liabilities 2010-2023 | RHHBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Roche Holding AG total long term liabilities from 2010 to 2023. Total long term liabilities can be defined as the sum of all non-current liabilities.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$711.9B
Novo Nordisk (NVO)
$460.6B
Johnson & Johnson (JNJ)
$374.4B
AbbVie (ABBV)
$303.5B
Merck (MRK)
$252.6B
Novartis AG (NVS)
$212.3B
AstraZeneca (AZN)
$199.2B
Pfizer (PFE)
$142.4B
Sanofi (SNY)
$121.8B
Innoviva (INVA)
$1.2B